Jazz Pharmaceuticals plc — Director's Dealing 2022

Aug 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-08-18

Reporting Person: Gray Peter (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	Ordinary Shares	M	8000	$55.28	Acquired	22234	Direct
2022-08-18	Ordinary Shares	S	8000	$158.0	Disposed	14234	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-18	Non-Qualified Stock Option (right to buy)	$55.28	M	8000	Disposed	2023-05-08	Ordinary Shares (8000)	Direct

Footnotes

F1: This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter.